23andMe to delist from Nasdaq, deregister with SEC

23andMe to delist from Nasdaq, deregister with SEC


A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024.

Justin Sullivan | Getty Images

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for Chapter 11 bankruptcy protection in March.

This is breaking news. Please refresh for updates.



Source

Anthropic unveils plans for major UK expansion after OpenAI announces first permanent London office
Technology

Anthropic unveils plans for major UK expansion after OpenAI announces first permanent London office

Anthropic said Thursday it’s expanding its presence in London with new office space for 800 people, days after rival OpenAI unveiled plans for its first permanent office in the U.K. capital. The maker of the Claude AI chatbot currently has more than 200 people based in London, the company said in a statement. “London is […]

Read More
The public sours on AI and data centers as Anthropic, OpenAI look to IPO and tech keeps spending
Technology

The public sours on AI and data centers as Anthropic, OpenAI look to IPO and tech keeps spending

Artificial intelligence is losing the popularity contest in the United States, and that’s bad news for some of Big Tech’s power players. The trend has implications for richly valued companies like OpenAI and Anthropic, which are both on the path to go public. It also threatens Amazon, Google, Microsoft and Meta, the so-called hyperscalers planning […]

Read More
Cramer’s lightning round: Nokia still has room to run
Technology

Cramer’s lightning round: Nokia still has room to run

Stock Chart IconStock chart icon Gilead Sciences’ year-to-date stock performance. Gilead Sciences: “I like what Daniel O’Day is doing…I think he’s a smart guy, and the company’s good. I’d hold on to it. They’ve got some good franchises.” Stock Chart IconStock chart icon AST SpaceMobile’s year-to-date stock performance. AST Space Mobile: “I like it very […]

Read More